Clinical Trial Update: Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigates the combination of topotecan and paclitaxel for recurrent or metastatic cervical cancer. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Topotecan (topotecan)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED